Russell Investments Group, Ltd. Rvl Pharmaceuticals PLC Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$3.26 - $4.84 $175,951 - $261,229	-53,973 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$4.12 - $6.29 $174,733 - $266,765	-42,411 Reduced 44.0%	53,973 $222,000
Q3 2020 Nov 09, 2020	BUY	$4.82 - $8.77 $60,250 - $109,625	12,500 Added 14.9%	96,384 $521,000
Q2 2020 Aug 05, 2020	SELL	$2.83 - $6.99 $10,236 - $25,282	-3,617 Reduced 4.13%	83,884 $564,000
Q1 2020 May 06, 2020	BUY	$3.18 - $7.0 $278,253 - $612,507	87,501 New	87,501 $277,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.